Back to Journals » Therapeutics and Clinical Risk Management » Volume 13

Alemtuzumab: a review of efficacy and risks in the treatment of relapsing remitting multiple sclerosis

Total article views   Abstract views HTML views PDF downloads Totals
14,260 Dovepress* 6,004 2,401+ 1,303 8,405
PubMed Central* 0 5,855 960 5,855
Totals 6,004 8,256 2,263 14,260
*Since 14 July 2017
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
14 1 0 0 4 9

View citations on PubMed Central and Google Scholar